These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 33682628
21. Assessment of CYP450 genetic variability effect on methadone dose and tolerance. Tsai HJ, Wang SC, Liu SW, Ho IK, Chang YS, Tsai YT, Lin KM, Liu YL. Pharmacogenomics; 2014 May; 15(7):977-86. PubMed ID: 24956251 [Abstract] [Full Text] [Related]
22. Methadone Dosage and Plasma Levels, SNPs of OPRM1 Gene and Age of First Drug Use Were Associated With Outcomes of Methadone Maintenance Treatment. Peng S, Jiang H, Du J, Lin S, Pan S, Yu S, Zhao M. Front Genet; 2018 May; 9():450. PubMed ID: 30420869 [Abstract] [Full Text] [Related]
24. Increased DNA Methylation of ABCB1, CYP2D6, and OPRM1 Genes in Newborn Infants of Methadone-Maintained Opioid-Dependent Mothers. McLaughlin P, Mactier H, Gillis C, Hickish T, Parker A, Liang WJ, Osselton MD. J Pediatr; 2017 Nov 15; 190():180-184.e1. PubMed ID: 28867064 [Abstract] [Full Text] [Related]
25. Pharmacogenomics of methadone maintenance treatment. Somogyi AA, Barratt DT, Ali RL, Coller JK. Pharmacogenomics; 2014 May 15; 15(7):1007-27. PubMed ID: 24956254 [Abstract] [Full Text] [Related]
26. ABCB1, CYP2B6, and CYP3A4 genetic polymorphisms do not affect methadone maintenance treatment in HCV-positive patients. Sutlović D, Ključević Ž, Kuret S. Arh Hig Rada Toksikol; 2020 Dec 31; 71(4):353-358. PubMed ID: 33410778 [Abstract] [Full Text] [Related]
27. Influence of UGT2B7, CYP3A4, and OPRM1 Gene Polymorphisms on Transdermal Buprenorphine Pain Control in Patients with Critical Lower Limb Ischemia Awaiting Revascularization. Blanco F, Muriel C, Labrador J, Gonzalez-Porras JR, Gonzalez-Sarmiento R, Lozano FS. Pain Pract; 2016 Sep 31; 16(7):842-9. PubMed ID: 26407542 [Abstract] [Full Text] [Related]
28. Methadone serum concentrations and influencing factors: A naturalistic observational study. Chalabianloo F, Westin AA, Skogvoll E, Bramness JG, Spigset O. Psychopharmacology (Berl); 2019 Nov 31; 236(11):3159-3167. PubMed ID: 31139877 [Abstract] [Full Text] [Related]
29. Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran. Farnia M, Ebrahimi B, Shams A, Zamani S. Int J Drug Policy; 2010 Sep 31; 21(5):422-4. PubMed ID: 20413287 [Abstract] [Full Text] [Related]
30. Association study of genetic polymorphisms in GABRD with treatment response and dose in methadone maintenance treatment. Xie X, Gu J, Zhuang D, Chen X, Zhou Y, Shen W, Li L, Liu Y, Xu W, Hong Q, Chen W, Zhou W, Liu H. Per Med; 2021 Sep 31; 18(5):423-430. PubMed ID: 34160285 [Abstract] [Full Text] [Related]
31. The AC/AG Diplotype for the 118A>G and IVS2 + 691G>C Polymorphisms of OPRM1 Gene is Associated with Sleep Quality Among Opioid-Dependent Patients on Methadone Maintenance Therapy. Zahari Z, Lee CS, Ibrahim MA, Musa N, Mohd Yasin MA, Lee YY, Tan SC, Mohamad N, Ismail R. Pain Ther; 2016 Jun 31; 5(1):43-54. PubMed ID: 26792136 [Abstract] [Full Text] [Related]
32. Evaluation of an implementation of methadone maintenance treatment in China. Marienfeld C, Liu P, Wang X, Schottenfeld R, Zhou W, Chawarski MC. Drug Alcohol Depend; 2015 Dec 01; 157():60-7. PubMed ID: 26601934 [Abstract] [Full Text] [Related]
33. Pharmacologic evidence to support clinical decision making for peripartum methadone treatment. Bogen DL, Perel JM, Helsel JC, Hanusa BH, Romkes M, Nukui T, Friedman CR, Wisner KL. Psychopharmacology (Berl); 2013 Jan 01; 225(2):441-51. PubMed ID: 22926004 [Abstract] [Full Text] [Related]
34. Community-Based Methadone Maintenance in a Large Detention Center is Associated with Decreases in Inmate Recidivism. Westerberg VS, McCrady BS, Owens M, Guerin P. J Subst Abuse Treat; 2016 Nov 01; 70():1-6. PubMed ID: 27692182 [Abstract] [Full Text] [Related]
35. Patient perception of methadone dose adequacy in methadone maintenance treatment: The role of perceived participation in dosage decisions. Trujols J, González-Saiz F, Manresa MJ, Alcaraz S, Batlle F, Duran-Sindreu S, Pérez de Los Cobos J. Patient Educ Couns; 2017 May 01; 100(5):981-986. PubMed ID: 27988071 [Abstract] [Full Text] [Related]
36. APBB2 is associated with amphetamine use and plasma beta-amyloids in patients receiving methadone maintenance treatment. Liu CC, Fang CP, Liu TH, Kuo HW, Liu SC, Wang SC, Chen ACH, Liu YL. Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr 20; 83():92-98. PubMed ID: 29330135 [Abstract] [Full Text] [Related]
37. Efficacy of chronic hepatitis C therapy with pegylated interferon and ribavirin in patients on methadone maintenance treatment. Neukam K, Mira JA, Gilabert I, Claro E, Vázquez MJ, Cifuentes C, García-Rey S, Merchante N, Almeida C, Macías J, Pineda JA. Eur J Clin Microbiol Infect Dis; 2012 Jun 20; 31(6):1225-32. PubMed ID: 21971821 [Abstract] [Full Text] [Related]
38. Auditory event-related potentials in methadone substituted opiate users. Wang GY, Kydd R, Russell BR. J Psychopharmacol; 2015 Sep 20; 29(9):983-95. PubMed ID: 26038111 [Abstract] [Full Text] [Related]
39. Factors affecting the dose of methadone among patients receiving methadone maintenance therapy in Taiwan. Li DJ, Chung KS, Wu HC, Hsu CY, Yen CF. Am J Addict; 2018 Apr 20; 27(3):225-230. PubMed ID: 29569392 [Abstract] [Full Text] [Related]
40. Interindividual variability of methadone response: impact of genetic polymorphism. Li Y, Kantelip JP, Gerritsen-van Schieveen P, Davani S. Mol Diagn Ther; 2008 Apr 20; 12(2):109-24. PubMed ID: 18422375 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]